Pharmacotherapy for the peripartum management of bipolar disorder

References

• Goodwin FK, Jamison KR, Ghaemi SN. Manic-depressive illness: bipolar disorders and recurrent depression. 2nd ed. New York, N.Y.: Oxford University Press; 2007.
   Google Scholar
• Grande I, Berk M, Birmaher B, et al. Bipolar disorder. Lancet. 2016;387(10027):1561–1572.
   PubMed Web of Science ®Google Scholar
• Vieta E, Berk M, Schulze TG, et al. Bipolar disorders. Nat Rev Dis Primers 2018;4:18008
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand college of psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015;49(12):1087–1206.
   PubMed Web of Science ®Google Scholar
• Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013;170(11):1249–1262.
   PubMed Web of Science ®Google Scholar
• Murru A, Pacchiarotti I, Verdolini N, et al. Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2018;268(8):749–755.
   PubMed Web of Science ®Google Scholar
• Samalin L, Murru A, Vieta E. Management of inter-episodic periods in patients with bipolar disorder. Expert Rev Neurother. 2016;16(6):659–670.
   PubMed Web of Science ®Google Scholar
• Sole B, Bonnin CM, Jimenez E, et al. Heterogeneity of functional outcomes in patients with bipolar disorder: a cluster-analytic approach. Acta Psychiatr Scand. 2018;137(6):516–527.
   PubMed Web of Science ®Google Scholar
• Biel MG, Peselow E, Mulcare L, et al. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study. Bipolar Disord. 2007;9(5):435–442.
   PubMed Web of Science ®Google Scholar
• Colom F, Vieta E, Sanchez-Moreno J, et al. Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry. 2009;194(3):260–265.
   PubMed Web of Science ®Google Scholar
• Wesseloo R, Kamperman AM, Munk-Olsen T, et al. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry. 2016;173(2):117–127.
   PubMed Web of Science ®Google Scholar
• Grigoriadis S, Wilton AS, Kurdyak PA, et al. Perinatal suicide in Ontario, Canada: a 15-year population-based study. Cmaj. 2017;189(34):E1085–E92.
   PubMed Web of Science ®Google Scholar
• Pawlby S, Fernyhough C, Meins E, et al. Mind-mindedness and maternal responsiveness in infant-mother interactions in mothers with severe mental illness. Psychol Med. 2010;40(11):1861–1869.
   PubMed Web of Science ®Google Scholar
• Boukakiou R, Glangeaud-Freudenthal NMC, Falissard B, et al. Impact of a prenatal episode and diagnosis in women with serious mental illnesses on neonatal complications (prematurity, low birth weight, and hospitalization in neonatal intensive care units). Arch Womens Ment Health 2018 Oct 5. DOI: 10.1007/s00737-018-0915-1
   PubMed Web of Science ®Google Scholar
• Graham RK, Tavella G, Parker GB. Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period? J Affect Disord. 2018;228:216–221.
   PubMed Web of Science ®Google Scholar
• Verdolini N, Hidalgo-Mazzei D, Murru A, et al. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines. Acta Psychiatr Scand. 2018;138(3):196–222.
   PubMed Web of Science ®Google Scholar
• Graham R, Mancher M, Wolman D, et al. Clinical practice guidelines we can trust. Washington, DC: National Academies Press; 2011.
   Google Scholar
• Fountoulakis KN, Grunze H, Vieta E, et al. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), Part 3: the clinical guidelines. Int J Neuropsychopharmacol. 2017;20(2):180–195.
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Haddad PM, Ferrier IN, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British association for psychopharmacology. J Psychopharmacol. 2016;30(6):495–553.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14(3):154–219.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10(2):85–116.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010;11(2):81–109.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Pregnancy and Lactation (Drugs) Final Rule. White Oak, MD: FDA/Drugs; 2014. [cited 2019 Feb 28]. Available from: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm
   Google Scholar
• Vajda FJ, O’Brien TJ, Lander CM, et al. The teratogenicity of the newer antiepileptic drugs - an update. Acta Neurol Scand. 2014;130(4):234–238.
   PubMed Web of Science ®Google Scholar
• McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721–728.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Wisner KL, Stowe Z, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004;161(4):608–620.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. New Measures to Avoid Valproate Exposure in Pregnancy Endorsed. Amsterdam, NL: EMA/sciences medicines health; 2018. [cited 2019 Feb 28]. Available from: https://www.ema.europa.eu/en/documents/referral/valproate-article-31-referral-new-measures-avoid-valproate-exposure-pregnancy-endorsed_en-0.pdf
   Google Scholar
• Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164(12):1817–1824.
   PubMed Web of Science ®Google Scholar
• Boden R, Lundgren M, Brandt L, et al. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. Bmj. 2012;345:e7085.
   PubMed Web of Science ®Google Scholar
• Patorno E, Huybrechts KF, Bateman BT, et al. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med. 2017;376(23):2245–2254.
   PubMed Web of Science ®Google Scholar
• Diav-Citrin O, Shechtman S, Tahover E, et al. Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry. 2014;171(7):785–794.
   PubMed Web of Science ®Google Scholar
• Pacchiarotti I, Leon-Caballero J, Murru A, et al. Mood stabilizers and antipsychotics during breastfeeding: focus on bipolar disorder. Eur Neuropsychopharmacol. 2016;26(10):1562–1578.
   PubMed Web of Science ®Google Scholar
• Viguera AC, Newport DJ, Ritchie J, et al. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry. 2007;164(2):342–345.
   PubMed Web of Science ®Google Scholar
• Samalin L, Genty JB, Boyer L, et al. Shared decision-making: a systematic review focusing on mood disorders. Curr Psychiatry Rep 2018;20(4):23
   PubMed Web of Science ®Google Scholar
• Fisher A, Manicavasagar V, Kiln F, et al. Communication and decision-making in mental health: a systematic review focusing on bipolar disorder. Patient Educ Couns. 2016;99(7):1106–1120.
   PubMed Web of Science ®Google Scholar
• Tuckett D. Meeting between experts: an approach to sharing ideas in medical consultations. New York: Routledge; 1986.
   Google Scholar
• Elwyn G, Laitner S, Coulter A, et al. Implementing shared decision making in the NHS. Bmj 2010;341:c5146
   PubMed Web of Science ®Google Scholar
• Poels EMP, Schrijver L, Kamperman AM, et al. Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2018;27(9):1209–1230.
   PubMed Web of Science ®Google Scholar
• Santucci AK, Singer LT, Wisniewski SR, et al. One-year developmental outcomes for infants of mothers with bipolar disorder. J Clin Psychiatry. 2017;78(8):1083–1090.
   PubMed Web of Science ®Google Scholar
• Vieta E, Arango C, Rush AJ. The need for paediatric registries to assess long-term brain effects of psychotropic medications: the case of bipolar disorder. Eur Neuropsychopharmacol. 2018;28(11):1181–1184.
   PubMed Web of Science ®Google Scholar
• Orsolini L, Valchera A, Vecchiotti R, et al. Suicide during perinatal period: epidemiology, risk factors, and clinical correlates. Front Psychiatry 2016;7:138
   PubMed Web of Science ®Google Scholar
• Belzeaux R, Boyer L, Mazzola-Pomietto P, et al. Adherence to medication is associated with non-planning impulsivity in euthymic bipolar disorder patients. J Affect Disord. 2015;184:60–66.
   PubMed Web of Science ®Google Scholar
• Correard N, Consoloni JL, Raust A, et al. Neuropsychological functioning, age, and medication adherence in bipolar disorder. PLoS One 2017;12(9):e0184313
   PubMed Web of Science ®Google Scholar